10
Dec
2024

Alesraa Pharmaceutical Optime

Exhibitor at CPHI Middle East 2024 stand 2.C78
About Us

Alesraa Pharmaceutical Optima, based in Cairo, Egypt, is a prominent leader in the Egyptian pharmaceutical industry, specializing in the manufacturing and commercialization of generic pharmaceuticals and dietary supplements. We provide contract development and manufacturing services for the pharmaceutical and nutraceutical industries, where our dedication lies in delivering premium products with an unwavering commitment to exceeding customer expectations. Responding to the rising demand for nutritional supplements, we expanded our manufacturing capabilities in 2022 by establishing a ...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • EG
  • 2024
    On CPHI since
  • 2
    Certificates
  • 500 - 999
    Employees
Company types
Generics/Biosimilars Manufacturer
Primary activities
Contract Manufacturer
Cosmeceuticals
Nutraceuticals
Pharmaceutical Company (generic finished products)
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Middle East 2024
  • 10 Dec 2024 - 12 Dec 2024
  • Riyadh Front Exhibition & Convention Center Riyadh, Saudi Arabia
  • Visit us at stand 2.C78

Products Featured at CPHI Middle East 2024

  • Allergicasone

    Product Allergicasone

    Allergicasone combines 125 mg of azelastine, a potent antihistamine, and 50 mcg of fluticasone propionate, a powerful corticosteroid, to provide comprehensive relief from allergic rhinitis symptoms. The dual-action formula targets both histamine release and inflammation, effectively reducing nasal congesti...
  • Dapablix/Dapablix Met

    Product Dapablix/Dapablix Met

    Dapablix contains dapagliflozin, an SGLT2 inhibitor that effectively reduces blood glucose levels by promoting renal glucose excretion. It is indicated for the management of type 2 diabetes mellitus, offering additional benefits such as weight reduction and cardiovascular risk mitigation.
    Dapablix Met c...
  • Larosuzet

    Product Larosuzet

    Larosuzet integrates the strengths of ezetimibe, an intestinal cholesterol absorption inhibitor, and rosuvastatin, an HMG-CoA reductase inhibitor, to achieve optimal lipid control. This dual-action formula reduces LDL-C and total cholesterol levels more effectively than either agent alone. Larosuzet is sui...
  • Vonacidan

    Product Vonacidan

    Vonacidan (Vonoprazan 10 mg and 20 mg film-coated tablets) a potent potassium-competitive acid blocker (P-CAB) that offers rapid and sustained suppression of gastric acid secretion. Unlike traditional proton pump inhibitors (PPIs), Vonacidan provides faster onset and more stable pH control, making it ...